| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-11 16:50:51 UTC |
|---|
| Updated at | 2022-05-11 16:50:51 UTC |
|---|
| NP-MRD ID | NP0087481 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 7alpha,25-Dihydroxycholesterol |
|---|
| Description | 4-Oxo-Retinoic acid, also known as 4-oxo-retinoate or 4-oxo-atra, belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. 4-Oxo-Retinoic acid is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. 4-Oxo-retinoic acid can be biosynthesized from 4-hydroxyretinoic acid; which is catalyzed by the enzyme cytochrome P450 26A1. In humans, 4-oxo-retinoic acid is involved in retinol metabolism. 7alpha,25-Dihydroxycholesterol was first documented in 1979 (PMID: 435468). A retinoid that consists of all-trans-retinoic acid bearing an oxo substituent at position 4 on the cyclohexenyl ring (PMID: 2051220) (PMID: 25492813) (PMID: 2772923) (PMID: 8794203). |
|---|
| Structure | [H][C@@]12CC[C@H]([C@H](C)CCCC(C)(C)O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](O)C=C2C[C@@H](O)CC[C@]12C InChI=1S/C27H46O3/c1-17(7-6-12-25(2,3)30)20-8-9-21-24-22(11-14-27(20,21)5)26(4)13-10-19(28)15-18(26)16-23(24)29/h16-17,19-24,28-30H,6-15H2,1-5H3/t17-,19+,20-,21+,22+,23-,24+,26+,27-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 4-oxo-all-trans-Retinoic acid | ChEBI | | 4-oxo-AtRA | ChEBI | | 4-oxo-all-trans-Retinoate | Generator | | 4-oxo-Retinoate | Generator | | 4-Keto-retinoate | HMDB | | 4-Keto-retinoic acid | HMDB | | 4-Ketoretinoate | HMDB | | 4-Ketoretinoic acid | HMDB | | 4-Oxoretinoate | HMDB | | 4-Oxoretinoic acid | HMDB | | 4-Oxotretinoin | HMDB | | all-trans-4-Oxoretinoate | HMDB | | all-trans-4-Oxoretinoic acid | HMDB | | Ro 11-4824 | HMDB | | Ro 12-4824 | HMDB | | 4-oxo-13-cis-Retinoic acid | HMDB | | 4-oxo-Isotretinoin | HMDB | | 4-oxo-trans-Retinoic acid | HMDB | | 4-Oxoretinoic acid, (13-cis)-isomer | HMDB | | 3beta,7alpha,25-Trihydroxycholest-5-ene | ChEBI | | 5-Cholesten-3beta,7alpha,25-triol | ChEBI | | Cholest-5-ene-3beta,7alpha,25-triol | ChEBI | | 3b,7a,25-Trihydroxycholest-5-ene | Generator | | 3β,7α,25-trihydroxycholest-5-ene | Generator | | 5-Cholesten-3b,7a,25-triol | Generator | | 5-Cholesten-3β,7α,25-triol | Generator | | Cholest-5-ene-3b,7a,25-triol | Generator | | Cholest-5-ene-3β,7α,25-triol | Generator | | 7-alpha,25-Dihydroxycholesterol | HMDB | | 7alpha,25-Dihydroxycholesterol | HMDB, KEGG | | Cholest-5-ene-3-b,7-a,25-triol | HMDB | | Cholest-5-ene-3-beta,7-alpha,25-triol | HMDB | | 7a,25-Dihydroxycholesterol | Generator | | 7Α,25-dihydroxycholesterol | Generator |
|
|---|
| Chemical Formula | C27H46O3 |
|---|
| Average Mass | 418.6523 Da |
|---|
| Monoisotopic Mass | 418.34470 Da |
|---|
| IUPAC Name | (1S,2R,5S,9S,10S,11S,14R,15R)-14-[(2R)-6-hydroxy-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-ene-5,9-diol |
|---|
| Traditional Name | 7α,25-dihydroxycholesterol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@]12CC[C@H]([C@H](C)CCCC(C)(C)O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H](O)C=C2C[C@@H](O)CC[C@]12C |
|---|
| InChI Identifier | InChI=1S/C27H46O3/c1-17(7-6-12-25(2,3)30)20-8-9-21-24-22(11-14-27(20,21)5)26(4)13-10-19(28)15-18(26)16-23(24)29/h16-17,19-24,28-30H,6-15H2,1-5H3/t17-,19+,20-,21+,22+,23-,24+,26+,27-/m1/s1 |
|---|
| InChI Key | BQMSKLCEWBSPPY-IKVTXIKFSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Retinoids |
|---|
| Direct Parent | Retinoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Retinoic acid
- Diterpenoid
- Retinoid skeleton
- Medium-chain fatty acid
- Cyclohexenone
- Methyl-branched fatty acid
- Branched fatty acid
- Fatty acyl
- Fatty acid
- Unsaturated fatty acid
- Ketone
- Cyclic ketone
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organooxygen compound
- Organic oxide
- Carbonyl group
- Hydrocarbon derivative
- Organic oxygen compound
- Aliphatic homomonocyclic compound
|
|---|
| Molecular Framework | Aliphatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|